Métodos de exploración del metabolismo del calcio y el fosfato

Nordin, 1976 Koumakis, 2020, The causes of hypo- and hyperphosphatemia in humans, Calcif Tissue Int Clase, 2000, Albumin-corrected calcium and ionized calcium in stable haemodialysis patients, Nephrol Dial Transplant, 15, 1841, 10.1093/ndt/15.11.1841 Ong, 2012, The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism, J Clin Endocrinol Metab, 97, 3138, 10.1210/jc.2012-1429 Heaney, 1999, Urinary calcium in perimenopausal women: normative values, Osteoporos Int, 9, 13, 10.1007/s001980050110 Walton, 1975, Nomogram for the derivation of renal threshold phosphate concentration, Lancet, 2, 309, 10.1016/S0140-6736(75)92736-1 Lepage, 1998, A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples, Clin Chem, 44, 805, 10.1093/clinchem/44.4.805 Souberbielle, 2001, Vitamin D status and redefining serum parathyroid hormone reference range in the elderly, J Clin Endocrinol Metab, 86, 3086 Souberbielle, 2003, The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects, J Clin Endocrinol Metab, 88, 3501, 10.1210/jc.2003-030097 Eastell, 2009, Diagnostic of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop, J Clin Endocrinol Metab, 94, 340, 10.1210/jc.2008-1758 Cavalier, 2012, Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values, Nephrol Dial Transplant, 27, 1950, 10.1093/ndt/gfr535 Benhamou, 2011, La vitamine D chez l’adulte: recommandations du GRIO, Presse Med, 40, 673, 10.1016/j.lpm.2011.04.001 Aloia, 2006, Optimal vitamin D status and serum parathyroid hormone concentrations in African American women, Am J Clin Nutr, 84, 602, 10.1093/ajcn/84.3.602 Priemel, 2010, Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients, J Bone Miner Res, 25, 305, 10.1359/jbmr.090728 Okazaki, 2011, Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D3 load in Japanese subjects, J Bone Miner Metab, 29, 103, 10.1007/s00774-010-0200-5 Bischoff-Ferrari, 2009, Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials, Arch Intern Med, 169, 551, 10.1001/archinternmed.2008.600 Carmel, 2012, The 25(OH) D level to maintain a favourable bisphosphonate response is >33ng/ml, Osteoporos Int, 23, 2479, 10.1007/s00198-011-1868-7 Ross, 2011, The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know, J Clin Endocrinol Metab, 96, 53, 10.1210/jc.2010-2704 Mithal, 2009, IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D, Osteoporos Int, 11, 1807, 10.1007/s00198-009-0954-6 Holick, 2006, Resurrection of vitamin D deficiency and rickets, J Clin Invest, 116, 2062, 10.1172/JCI29449 Luxwolda, 2012, Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l, Br J Nutr, 108, 1557, 10.1017/S0007114511007161 Hathcock, 2007, Risk assessment for vitamin D, Am J Clin Nutr, 85, 6, 10.1093/ajcn/85.1.6 Stolzenberg-Solomon, 2010, Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers, Am J Epidemiol, 172, 81, 10.1093/aje/kwq120 Tuohimaa, 2004, Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries, Int J Cancer, 108, 104, 10.1002/ijc.11375 Souberbielle, 2015, Serum calcitriol concentrations measured with a new direct automated assay in a large population of adult healthy subjects and in various clinical situations, Clin Chim Acta, 451, 149, 10.1016/j.cca.2015.09.021 Schlingmann, 2011, Mutations in CYP24A1 and idiopathic infantile hypercalcemia, N Engl J Med, 365, 410, 10.1056/NEJMoa1103864 Brown, 2012, Bioavailable vitamin D in chronic kidney disease, Kidney Int, 82, 5, 10.1038/ki.2012.135 Powe, 2013, Vitamin D-binding protein and vitamin D status of black Americans and white Americans, N Engl J Med, 369, 1991, 10.1056/NEJMoa1306357 Dastani, 2014, In healthy adults, biological activity of vitamin D, as assessed by serum PTH, is largely independent of DBP concentrations, J Bone Miner Res, 29, 494, 10.1002/jbmr.2042 Chun, 2014, Vitamin D and DBP: the free hormone hypothesis revisited, J Steroid Biochem Mol Biol, 144, 132, 10.1016/j.jsbmb.2013.09.012 Bhattacharyya, 2012, Fibroblast growth factor 23: state of the field and future directions, Trends Endocrinol Metab, 12, 610, 10.1016/j.tem.2012.07.002 Garnero, 2000, Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC Workgroup, Ann Biol Clin, 58, 683 Delmas, 2000, Committee of scientific Advisors of the International osteoporosis Foundation. The use of biochemical markers of bone turnover in the management of post-menopausal osteoporosis, Osteoporosis Int, 11, S2, 10.1007/s001980070002 Miller, 1999, Practical clinical application of biochemical markers of bone turnover. Consensus of an expert panel, J Clin Densitometry, 2, 323, 10.1385/JCD:2:3:323 Briot, 2018, 2018 Update of French Recommendations on the management of postmenopausal osteoporosis, Joint Bone Spine, 85, 519, 10.1016/j.jbspin.2018.02.009 Stewart, 2005, Clinical practice. Hypercalcemia associated with cancer, N Engl J Med, 352, 373, 10.1056/NEJMcp042806 Cormier, 2019, Genetic hypercalcemia, Joint Bone Spine, 86, 459, 10.1016/j.jbspin.2018.10.001 Pak, 1979, Physiological basis for absorptive and renal hypercalciurias, Am J Physiol, 237, F415 Eisner, 2009, Differentiating primary from secondary hyperparathyroidism in stone patients : the “thiazide challenge”, J Endourol, 23, 191, 10.1089/end.2008.0567 Broadus, 1980, Primary hyperparathyroidism with intermittent hypercalcemia: serial observations and simple diagnosis by means of an oral calcium tolerance test, Clin Endocrinol, 12, 225, 10.1111/j.1365-2265.1980.tb02704.x Broadus, 1978, Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test, J Clin Endocrinol Metab, 46, 477, 10.1210/jcem-46-3-477 Cadiot, 1996, Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de recherche et d’étude du Syndrome de Zollinger-Ellison, Gut, 39, 273, 10.1136/gut.39.2.273 Hagag, 2003, Diagnosis of normocalcemic hyperparathyroidism by oral calcium loading test, Endocrinol Invest, 26, 327, 10.1007/BF03345180 Titon, 2007, Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism, Eur J Endocrinol, 157, 351, 10.1530/EJE-07-0132 Gupta, 2010, Presence of impaired intestinal calcium absorption in chronic hypovitaminosis D and its change after cholecalciferol supplementation: assessment by the calcium load test, Hum Nutr Diet, 23, 54, 10.1111/j.1365-277X.2009.01003.x Pak, 1975, A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias, N Engl J Med, 292, 497, 10.1056/NEJM197503062921002 Broadus, 1978, Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups, J Clin Endocrinol Metab, 47, 751, 10.1210/jcem-47-4-751 Slovik, 1984, Renal 1.25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone-(1-34) administration in normal subjects, Clin Endocrinol, 20, 369, 10.1111/j.1365-2265.1984.tb03432.x Miura, 1990, Response of plasma 1.25-dihydroxyvitamin D in the human PTH(1-34) infusion test: an improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism, Calcif Tissue Int, 46, 309, 10.1007/BF02563821 Walsh, 2001, Urinary acidification assessed by simultaneous furosemide and fludrocortisone treatment: an alternative to ammonium chloride, Kidney Int, 71, 1310, 10.1038/sj.ki.5002220 Cailleux, 2015, A step towards cinacalcet testing for the diagnosis of primary hyperparathyroidism: comparison with the standardized intravenous calcium loading. A pilot study, Clin Endocrinol, 8, 663, 10.1111/cen.12729 Bertocchio, 2018, Pro-FHH: a risk equation to facilitate the diagnosis of parathyroid-related hypercalcemia, J Clin Endocrinol Metab, 103, 2534, 10.1210/jc.2017-02773 Jacobs, 2005, Clinical review: rare causes of hypercalcemia, J Clin Endocrinol Metab, 90, 6316, 10.1210/jc.2005-0675 Rejnmark, 2011, Increased fracture risk in normocalcemic postmenopausal women with high parathyroid hormone levels: a 16-year follow-up study, Calcif Tissue Int, 88, 238, 10.1007/s00223-010-9454-0 Hureaux, 2019, High-throughput sequencing contributes to the diagnosis of tubulopathies and familial hypercalcemia hypocalciuria in adults, Kidney Int, 96, 1408, 10.1016/j.kint.2019.08.027 Worcester, 2008, New insights into the pathogenesis of idiopathic hypercalciuria, Semin Nephrol, 28, 120, 10.1016/j.semnephrol.2008.01.005 Parent, 2012, Pièges et contraintes des dosages du calcium, des phosphates et du magnésium. Métabolisme phosphocalcique monographie, Rev Rhum, 79, 221 Lafage-Proust, 2012, Insuffisance rénale et métabolisme du calcium et du phosphate. Monographie du metabolism phosphocalcique, Rev Rhum, 79, 221 Schafer, 2013, Hypocalcemia: definition, etiology, pathogenesis, diagnosis, and management. Primer on the metabolic bone diseases and disorders of mineral metabolism. American Society for Bone and Mineral Research, J Bone Miner Res, 572 Cusano, 2013, Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations, J Clin Endocrinol Metab, 98, 2734, 10.1210/jc.2013-1300 Souberbielle, 2015, How to manage an isolated elevated PTH, Ann Endocrinol, 76, 134, 10.1016/j.ando.2015.03.005 Koumakis, 2013, Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism, J Clin Endocrinol Metab, 98, 3213, 10.1210/jc.2013-1518